Price
$86.32-4.00%Social Signal Score
Analyst Ratings
16 analystsRevenue
$212.82M+204.71%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Daniel A. Perez
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 1,437
- Beta
- 1.36
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 9.24
Financials
Revenue
$212.82M+204.7%Net Income
$43.69MEBITDA
$45.49MFree Cash Flow
$99.56MEPS (diluted)
$0.53Shares Outstanding (diluted)
82.34M+5.5%Operating Expenses
$143.51MCash & Debt
$389.39MReturn of Capital
$26.52MRevenue by Segment (annual)
$587.86MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $587.86M | $-528.26M | $-5.36 |
| 2024 | $390.40M | $-11.93M | $-0.15 |
| 2023 | $292.73M | $-108.14M | $-1.39 |
Valuation
HNGEhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-28.57%Social Signal Score
Mentions (17)
- 4chan /biz/biz·4d ago·Neutral
Is paying for a personal stylist a high ROI activity? I've #made-it. I've got photos of me in a Porsche on Hinge, which is enough to land dates, but one of the girls I went out with told me I dress like a toddler, and she's not going to date a man who has to dress like a toddler. Any recs? I found this website, but it doesn't seem to be launched yet :(
View source ↗ - Newsmarketbeat.com·7d ago·Negative
3 Healthcare Stocks Showing Why the Sector Still Has Momentum The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.
View source ↗ - Newszacks.com·14d ago·Positive
Reasons to Hold Hinge Health Stock in Your Portfolio for Now HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
View source ↗ - 4chan /biz/biz·34d ago·Negative
Golden opportunity to short Hinge and Bumble once this crazy woman gets off scot-free.
View source ↗ - News (RSS)decrypt·38d ago·Positive
Fed Chair Warsh Calls AI a 'Hinge Point in History'—4 Key Things He Said Fed Chair Warsh devoted a full section of his speech today at Jackson Hole to AI's weight on the economy. Here are the biggest takeaways.
View source ↗ - News (RSS)yahoo·45d ago·Positive
IPO Stock Of The Week: Hinge Health Finds Support At Key Level, Eyes New Buy Points
View source ↗ - Newsinvestors.com·45d ago·Neutral
IPO Stock Of The Week: Hinge Health Finds Support At Key Level, Eyes New Buy Points Hinge stock found support at a key level in recent weeks and is approaching multiple new buy points despite market weakness.
View source ↗ - Newsmarketbeat.com·47d ago·Neutral
One Platform, Every Ailment: Hinge Health's Gamble Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating individual symptoms means a separate doctor visit, sometimes to different specialists, before the full picture emerges.
View source ↗ - News (RSS)yahoo·47d ago·Positive
IBD Stock Of The Day, Hinge, Eyes A Fresh Entry On Earnings-Tied Rally
View source ↗ - Newszacks.com·47d ago·Neutral
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue? Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.
View source ↗ - Newszacks.com·52d ago·Positive
Reasons to Hold Hinge Health Stock in Your Portfolio for Now HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
View source ↗ - Newszacks.com·54d ago·Positive
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise? HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
View source ↗ - Newszacks.com·54d ago·Neutral
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
View source ↗ - Newszacks.com·54d ago·Positive
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
View source ↗ - Newszacks.com·54d ago·Negative
Is the Options Market Predicting a Spike in Hinge Health Stock? Investors need to pay close attention to HNGE stock based on the movements in the options market lately.
View source ↗ - Newsbenzinga.com·55d ago·Positive
Jim Cramer Recommends Buying This Health Care Stock: ‘What A Quarter They Had' On CNBC's “Mad Money Lightning Round,” Jim Cramer said Hinge Health, Inc. (NYSE:HNGE) is a buy. “What a quarter they had,” he added.
View source ↗ - Newszacks.com·56d ago·Positive
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
View source ↗
Earnings
Tue, Nov 3(in 4 weeks)
Consensus estimate $0.60 per share
Typical surprise +94.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$0.59 vs $0.61miss
- Tue, May 5$0.45 vs $0.39beat
- Tue, Feb 10$0.49 vs $0.04beat
- Tue, Nov 4$0.34 vs $0.24beat
- Tue, Aug 5$0.67 vs $0.09beat
- Mon, May 5$0.21 vs $0.09beat
Estimates and results for HNGE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HNGE officers and directors.
- Bought
- —
- Sold
- $94.4m
0 trades
45 trades
- Pursley Jamessold
- Pursley Jamessold
- Pursley Jamessold
- Mecklenburg Gabriel M.i.sold
- Mecklenburg Gabriel M.i.sold
- Mecklenburg Gabriel M.i.sold
- Mecklenburg Gabriel M.i.sold
- Mecklenburg Gabriel M.i.sold
49 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in HNGE.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.